-
Sanofi Acquires mRNA Developer in $3.2B Deal
Drug maker Sanofi is purchasing biotechnology company Translate Bio, a developer of messenger RNA vaccines and therapies, and a long-time collaborator.
-
Pharma Gains Synthetic DNA for Rare Diseases in $1B+ Deal
A French biopharmaceutical company is gaining access to a technology using synthetic nucleic acids to treat rare genetic neurological diseases.
-
Infographic – Majorities Favor U.S. Vaccine Mandates
As the more contagious delta variant becomes the dominant SARS-CoV-2 strain, a clear majority of American adults now favors employers mandating Covid-19 vaccines.
-
Going Freelance: What Engineers Need To Know
Becoming a full-time freelancer is an incredibly exciting time as you can finally take full responsibility for your work.
-
Pharma, Biotech Partner on Off-the-Shelf Cell Therapies
A biotechnology enterprise is teaming with a pharmaceutical company to develop off-the-shelf therapies for malfunctioning mitochondria, energy centers of cells.
-
Fine-Tuning Process Devised for Gene Therapies
Researchers designed a technique to adjust the volume of proteins from gene therapy released into patients, providing more control for complex diseases.
-
Trial Tests Psychedelic Drug Safety, Chemical Activity
A clinical trial is underway that tests an hallucinogenic compound among healthy adults as a potential treatment for mental health disorders.
-
FDA Clears Stem Cell Trial for Multiple Sclerosis
The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients to treat their cases of multiple sclerosis.
-
How To Safely Find A House Mate
If this is the first time you are renting out any type of room or space, you may be feeling a bit overwhelmed regarding the whole thing.
-
Alzheimer’s Digital Biomarkers Project Gains New Funds
A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia.